Health
Vaccine makers Pfizer and Moderna pledge massive boost to U.S. supply after sluggish rollout – The Washington Post
The increases needed to meet March delivery targets will be steep, however, and Biden administration officials expect the companies could come up slightly short….
Because of the dire need to vaccinate more people, we have ramped up production of doses, John Young, Pfizers chief business officer, told the House Energy and Commerce oversight and investigations subcommittee in prepared testimony.
But achieving a surge on that scale remains daunting. Pfizer and Moderna, the companies with the only authorized vaccines so far, will need to increase their combined deliveries to date of 75 million doses to reach their promised target of 220 million shots by March…
